"It is important to find out which factors in these foods are responsible for these associations," researcher Suvi Virtanen ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Researchers found that pumps over-delivered insulin during the ascent, but not enough to cause hypoglycemia. At the same time ...

The FDA has cleared its first automated insulin pump for adults with Type 2 diabetes, with Insulet’s Omnipod 5 delivery system opening the door to a population of more than 6 million people.

The U.S. Food and Drug Administration has approved the first-ever device that provides automated insulin dosing for people with type 2 diabetes. The U.S. Food and Drug Administration has approved ...

"Ultra-rapid acting insulin is a popular choice for people living with diabetes due to its fast response time. We are proud to be able to offer Lyumjev compatibility with our t:slim X2 pump as ...

Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device ...

300-unit insulin reservoir is more suitable for people with T2D who are interested in moving from multiple daily injections (MDI) to pump therapy, based on an average daily dose of 95.9 units of ...

AUSTIN (KXAN) — People living with diabetes who depend on insulin now have a different option that doesn’t require needles or pumps to regulate a person’s blood sugar. “People might think ...

Insulin options for people with Type 2 diabetes were limited to methods such as injection with a syringe, an insulin pen or an insulin pump ... car booster seats for kids too soon, study finds ...

Continuous blood glucose monitors, which are inserted just under the skin, or implanted in the body, can connect to smartphones, or to insulin pumps, avoiding the need for people to do regular ...

Modular Medical shares rose after hours as the company received Food and Drug Administration clearance for its MODD1 insulin pump. The stock was up 27%, to $2.49, surpassing the prior 52-week high ...